Asialoglycoprotein Receptor-Targeted Superparamagnetic Perfluorooctylbromide Nanoparticles

BACKGROUND: The decrease in asialoglycoprotein receptor (ASGPR) levels is observed in patients with chronic liver disease and liver tumor. The aim of our study was to develop ASGPR-targeted superparamagnetic perfluorooctylbromide nanoparticles (M-PFONP) and wonder whether this composite agent could...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Contrast Media Mol Imaging
Päätekijät: Li, Yang, Yang, Chao Feng, Zuo, Hui, Li, Ao, Das, Sushant Kumar, Yu, Jin Hong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi 2021
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8181107/
https://ncbi.nlm.nih.gov/pubmed/34131415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5510071
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia